Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01743131 · ClinicalTrials.gov registry record · Phase 2
Abatacept as GVHD Prophylaxis Phase 2
A Phase 2 study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 186
- Enrollment target
NCT01743131 is a Phase 2 study that has completed, run by Boston Children's Hospital. The registered enrollment target is 186 participants.
The verdict
NCT01743131, a Phase 2 study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 186 participants
- Enrollment target
Study Summary
This is a phase II multi-center, randomized, double blind, placebo-controlled trial. The investigators are doing this study to see if a new drug, abatacept, can be used together with a calcineurin inhibitor (cyclosporine or tacrolimus) and methotrexate to provide better protection against Acute Graft versus Host Disease (aGvHD) without causing more infections.
Interventions
- DRUG placebo
- DRUG Abatacept
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2013-02-01 |
| Est. Completion | 2024-03-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01743131
The ClinicalTrials.gov registry entry for NCT01743131 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01743131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01743131 about?
NCT01743131 is a clinical study titled "Abatacept as GVHD Prophylaxis Phase 2". This is a phase II multi-center, randomized, double blind, placebo-controlled trial. The investigators are doing this study to see if a new drug, abatacept, can be used together with a calcineurin inhibitor (cyclosporine or tacrolimus) and methotrexate to provide better protection against Acute Gra...
What is the current status of trial NCT01743131?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 186 participants. The study started on 2013-02-01. Estimated completion is 2024-03-30.
What interventions are being tested in trial NCT01743131?
The interventions under investigation include: placebo (DRUG), Abatacept (DRUG).
Who is sponsoring clinical trial NCT01743131?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.